[HTML][HTML] Chronic obstructive pulmonary disease and lung cancer: a review for clinicians
GJ Criner, A Agusti, H Borghaei… - … Diseases: Journal of …, 2022 - ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) and lung cancer are common global causes
of morbidity and mortality. Because both diseases share several predisposing risks, the 2 …
of morbidity and mortality. Because both diseases share several predisposing risks, the 2 …
Inhaled corticosteroid use and the incidence of lung cancer in COPD
S Suissa, S Dell'Aniello, AV Gonzalez… - European Respiratory …, 2020 - Eur Respiratory Soc
Background Inhaled corticosteroids (ICS) are suggested for potential chemoprevention of
lung cancer. Several observational studies in patients with chronic obstructive pulmonary …
lung cancer. Several observational studies in patients with chronic obstructive pulmonary …
Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States
Background Prior studies on the association between asthma and cancer show inconsistent
results. This study aimed to generate additional evidence on the association between …
results. This study aimed to generate additional evidence on the association between …
[HTML][HTML] Integrating comorbidities and phenotype-based medicine in patient-centered medicine in COPD
JL Lopez-Campos, B Ruiz-Duque… - Journal of Clinical …, 2020 - mdpi.com
Despite recent notable innovations in the management of chronic obstructive pulmonary
disease (COPD), no major advances in patient-centered medicine have been achieved …
disease (COPD), no major advances in patient-centered medicine have been achieved …
[HTML][HTML] Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer
AP Machado, AS Shaikh, A Saji, M Shatila, IG Oliva… - Cancers, 2024 - mdpi.com
Simple Summary Guidelines from oncologic societies recommend high-dose systemic
corticosteroids as the primary therapy with or without biologics for moderate to severe colitis …
corticosteroids as the primary therapy with or without biologics for moderate to severe colitis …
Avoiding immortal time bias in observational studies
We thank AJN Raymakers and co-workers for their letter, which clarifies the method of data
analysis used in their study of the association between inhaled corticosteroids (ICS) and …
analysis used in their study of the association between inhaled corticosteroids (ICS) and …
[HTML][HTML] Einbeziehung von Komorbiditäten und phänotypbasierter Medizin beim patientenzentrierten COPD-Management
JL Lopez-Campos, B Ruiz-Duque… - Kompass …, 2021 - karger.com
Trotz der jüngsten bedeutenden Innovationen in der Behandlung der chronisch-obstruktiven
Lungenerkrankung (chronic obstructive pulmonary disease, COPD) wurden in der …
Lungenerkrankung (chronic obstructive pulmonary disease, COPD) wurden in der …
Integrating Comorbidities and Phenotype-Based Medicine in Patient-Centered Medicine in COPD
JL López-Campos Bodineau, B Ruiz Duque… - 2020 - idus.us.es
Despite recent notable innovations in the management of chronic obstructive pulmonary
disease (COPD), no major advances in patient-centered medicine have been achieved …
disease (COPD), no major advances in patient-centered medicine have been achieved …
Avoiding immortal time bias in observational studies
AJN Raymakers, M Sadatsafavi, DD Sin… - European …, 2020 - Eur Respiratory Soc
Avoiding immortal time bias in observational studies | European Respiratory Society Skip to
main content Main menu Home Current issue ERJ Early View Past issues ERS Guidelines …
main content Main menu Home Current issue ERJ Early View Past issues ERS Guidelines …